National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

Found 2 cases where Vaccine targets Influenza or Pneumonia or Shingles (FLU(H1N1) or FLU3 or FLU4 or FLUA3 or FLUA4 or FLUC3 or FLUC4 or FLUN(H1N1) or FLUN3 or FLUN4 or FLUR3 or FLUR4 or FLUX or FLUX(H1N1) or H5N1 or PNC or PNC10 or PNC13 or PPV or VARZOS) and Symptom is Arterial thrombosis or Arterial thrombosis limb or Axillary vein thrombosis or Blood fibrinogen increased or Complement factor C1 increased or Complement factor C3 increased or Complement factor C4 increased or Complement factor increased or Deep vein thrombosis or Platelet adhesiveness increased or Platelet dysfunction or Platelet function test abnormal or Pulmonary embolism or Secondary thrombocytosis or Thrombectomy or Thrombin-antithrombin III complex increased or Thrombin time abnormal or Thrombocytopenia or Thrombocytopenic purpura or Thrombolysis or Thrombophlebitis or Thrombosis or Thrombotic microangiopathy or Thrombotic stroke or Thrombotic thrombocytopenic purpura or Vena cava embolism or Vena cava thrombosis or Venous occlusion and Patient Died and Vaccination Date from '2017-01-01' to '2018-12-31'

Government Disclaimer on use of this data

Table

   
AgeVaccine/ManufacturerVaccine DoseYear of DeathCountPercent
< 3 Years6VAX-F / GLAXOSMITHKLINE BIOLOGICALS220172100%
6VAX-F / GLAXOSMITHKLINE BIOLOGICALS2total2100%
6VAX-F / GLAXOSMITHKLINE BIOLOGICALStotal2100%
PNC13 / PFIZER/WYETH220172100%
PNC13 / PFIZER/WYETH2total2100%
PNC13 / PFIZER/WYETHtotal2100%
total4200%
UnknownVARZOS / GLAXOSMITHKLINE BIOLOGICALS12018150%
VARZOS / GLAXOSMITHKLINE BIOLOGICALS1total150%
VARZOS / GLAXOSMITHKLINE BIOLOGICALStotal150%
total150%
TOTAL† 5† 250%
† Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table. This is the reason why the Total Count is greater than 2 (the number of cases found), and the Total Percentage is greater than 100.



Case Details

VAERS ID: 1261110 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: South Carolina  
Vaccinated:2018-05-22
Onset:2018-05-01
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER (SHINGRIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Acute kidney injury, Anoxia, Autopsy, Blood creatinine increased, Blood sodium decreased, Blood urea increased, Bronchitis chronic, Cardiac arrest, Cardiogenic shock, Central venous catheterisation, Condition aggravated, Death, Endotracheal intubation, Feeding disorder, Fluid intake reduced, Glomerulonephritis membranous, Hyponatraemia, Hypotension, Hypovolaemia, Hypoxia, Influenza like illness, Malaise, Metabolic encephalopathy, Multiple organ dysfunction syndrome, Muscle contractions involuntary, Myalgia, Myocardial infarction, Pyrexia, Rash, Renal disorder, Renal tubular necrosis, Respiratory failure, Seizure, Shock, Tachycardia, Thrombocytopenia, Transaminases increased, Viral infection, Viral test negative
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Cardiac failure (narrow), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (narrow), Angioedema (broad), Asthma/bronchospasm (broad), Haematopoietic thrombocytopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Convulsions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, venous (narrow), Dystonia (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Hyponatraemia/SIADH (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Renovascular disorders (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Chronic kidney disease (broad), Hypersensitivity (narrow), Tumour lysis syndrome (broad), Tubulointerstitial diseases (broad), Respiratory failure (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Hypoglycaemia (broad), Infective pneumonia (broad), Dehydration (narrow), Hypokalaemia (broad), Sepsis (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2018-05-30
   Days after onset: 29
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: RITUXIMAB
Current Illness: Glomerulonephritis membranous (diagnosed with membranous glomerulonephritis); Renal disorder (had long standing kidney problems)
Preexisting Conditions: Medical History/Concurrent Conditions: Biopsy (had a biopsy on February 2018.)
Allergies:
Diagnostic Lab Data: Test Date: 20180526; Test Name: Creatinine increased; Result Unstructured Data: (Test Result:value not reported,Unit:unknown,Normal Low:,Normal High:); Test Date: 20180526; Test Name: Hyponatremia; Result Unstructured Data: (Test Result:value not reported,Unit:unknown,Normal Low:,Normal High:); Test Date: 20180526; Test Name: Blood urea nitrogen increased; Result Unstructured Data: (Test Result:value not reported,Unit:unknown,Normal Low:,Normal High:); Test Date: 20180526; Test Name: body temperature; Result Unstructured Data: (Test Result:103.9,Unit:degree F,Normal Low:,Normal High:); Test Date: 201805; Test Name: lab test; Test Result: Negative ; Test Date: 20180526; Test Name: Transaminitis; Result Unstructured Data: (Test Result:value not reported,Unit:unknown,Normal Low:,Normal High:)
CDC Split Type: USGLAXOSMITHKLINEUS202109

Write-up: suffered spontaneous contractions / had a central line placed; tachycardic / (intubation removed after) and hypotensive; hypoxemia; Chronic bronquitis; never recovered pulmonary activity and died / Respiratory failure with hypoxemia; Elevated MI and shock; Elevated MI and shock; kidney problem / Diagnosed with membranous glomerulonephritis / worsened /hospitalized after getting worse; kidney problem / Diagnosed with membranous glomerulonephritis / worsened /hospitalized after getting worse; extremely ill kidneys shut down / developed acute renal failure; tubular necrosis; Metabolic encephalopathy (due to hyponatremia and anoxia); anoxia; Thrombocytopenia; hypotension (secondary to hypovolemia). /hypotensive; secondary to hypovolemia; Rash on the lower extremities; Decreased fluid and nourishment intake due to inability to eat and drink; Decreased fluid / due to inability to eat and drink; Hyponatremia; Transaminitis; Increased /creatinine; Increased BUN and creatinine; malaise; flu like symptoms / flu like illness; viral-like symptoms; myalgia; fever / Fever 103.9?F; multiorgan failure; rapidly decompensated with seizure; This case was reported by a physician via call center representative and described the occurrence of respiratory failure in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient''s past medical history included biopsy (had a biopsy on February 2018.). Previously administered products included prednisone, ciclosporin, immunosuppressive therapy (had exacerbation of the problem and was treated with immunosuppressive therapy using rituximab twice) and rituximab. Concurrent medical conditions included renal disorder (had long standing kidney problems) and glomerulonephritis membranous (diagnosed with membranous glomerulonephritis). Concomitant products included rituximab. On 22nd May 2018, the patient received the 1st dose of Shingrix. In May 2018, less than 2 weeks after receiving Shingrix, the patient experienced seizure (serious criteria hospitalization and GSK medically significant) and multi-organ failure (serious criteria hospitalization and GSK medically significant). On 22nd May 2018, the patient experienced influenza like illness (serious criteria hospitalization), viral infection (serious criteria hospitalization), myalgia (serious criteria hospitalization), fever (serious criteria hospitalization) and malaise (serious criteria hospitalization). On 26th May 2018, the patient experienced thrombocytopenia (serious criteria hospitalization and GSK medically significant), hypotension (serious criteria hospitalization), hypovolemia (serious criteria hospitalization), rash (serious criteria hospitalization), unable to eat (serious criteria hospitalization), fluid intake reduced (serious criteria hospitalization), hyponatremia (serious criteria hospitalization), transaminitis (serious criteria hospitalization), creatinine increased (serious criteria hospitalization) and blood urea nitrogen increased (serious criteria hospitalization). On 29th May 2018, the patient experienced respiratory failure (serious criteria death, hospitalization and GSK medically significant), myocardial infarction (serious criteria hospitalization and GSK medically significant), cardiogenic shock (serious criteria hospitalization and GSK medically significant), glomerulonephritis membranous (serious criteria hospitalization and GSK medically significant), condition aggravated (serious criteria hospitalization), acute renal failure (serious criteria hospitalization and GSK medically significant), tubular necrosis (serious criteria hospitalization and GSK medically significant), metabolic encephalopathy (serious criteria hospitalization and GSK medically significant), anoxia (serious criteria hospitalization and GSK medically significant), hypoxemia (serious criteria hospitalization and GSK medically significant) and chronic bronchitis (serious criteria hospitalization). On 30th May 2018, the patient experienced tachycardia (serious criteria hospitalization) and muscle contractions involuntary (serious criteria hospitalization). On 30th May 2018, the outcome of the respiratory failure was fatal. On an unknown date, the outcome of the myocardial infarction, cardiogenic shock, glomerulonephritis membranous, condition aggravated, acute renal failure, thrombocytopenia, tubular necrosis, metabolic encephalopathy, anoxia, seizure, hypoxemia, multi-organ failure, chronic bronchitis, hypotension, tachycardia, hypovolemia, muscle contractions involuntary, influenza like illness, viral infection, myalgia, fever, rash, malaise, unable to eat, fluid intake reduced, hyponatremia, transaminitis, creatinine increased and blood urea nitrogen increased were unknown. The patient died on 30th May 2018. The reported cause of death was respiratory failure. An autopsy was performed. It was unknown if the reporter considered the respiratory failure, myocardial infarction, cardiogenic shock, glomerulonephritis membranous, condition aggravated, acute renal failure, thrombocytopenia, tubular necrosis, metabolic encephalopathy, anoxia, seizure, hypoxemia, multi-organ failure, chronic bronchitis, hypotension, tachycardia, hypovolemia, muscle contractions involuntary, influenza like illness, viral infection, myalgia, fever, rash, malaise, unable to eat, fluid intake reduced, hyponatremia, transaminitis, creatinine increased and blood urea nitrogen increased to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient had long standing kidney problems and was various drugs for the past 20 years. The patient had last Rituximab treatment on 16th May 2018. As per MD (Doctor of Medicine) insistence patient got Shingrix vaccine. The patient experienced flu like symptoms, myalgia, fever and malaise and his condition worsened. On 26th May 2018, the patient was hospitalized after getting worse. The patient got extremely ill, kidneys shut down, there was hypotension (secondary to hypovolemia), decreased fluid and nourishment intake due to inability to eat and drink, fever 103.9 degree Fahrenheit, rash on the lower extremities, thrombocytopenia, hyponatremia decreased sodium, blood urea nitrogen increased and creatinine increased and transaminitis. Initial hospital could not do dialysis due to lack of equipment and was transferred to reporters hospital with a diagnose of membranous glomerulonephritis. On 29th May 2018, the patient was transferred to reporter''s hospital and patient died in less than 24 hours. The patient developed acute renal failure with tubular necrosis, respiratory failure with hypoxemia, chronic bronchitis (found in reporter''s hospital), metabolic encephalopathy (due to hyponatremia and anoxia), elevated MI (myocardial infarction) and shock. The patient had viral-like symptoms, tests for several common viruses came negative. As per physician notes patient rapidly decompensated with seizure and multiorgan failure, questionable meningitis versus immune response; pathologist (reporter) confirms patient did not have meningitis. On 30th May 2018, the patient was declared DNR (do-not-resuscitate) by family and later became asystolic, suffered spontaneous contractions and had a central line placed. The patient became tachycardic and hypotensive and was removed from intubation and 2 minutes later never recovered pulmonary activity and died. The health care professional was performing autopsy on a patient. No vaccine administration information available to reporter. The reporter consented to follow-up. This case had been linked with US2021090816, reported by the same reporter.; Sender''s Comments: US-GLAXOSMITHKLINE-US2021090816:same reporter (wife?s case); Reported Cause(s) of Death: Respiratory failure


VAERS ID: 690713 (history)  
Form: Version 1.0  
Age: 0.25  
Sex: Female  
Location: Foreign  
Vaccinated:2017-03-20
Onset:2017-03-21
   Days after vaccination:1
Submitted: 2017-04-14
   Days after onset:24
Entered: 2017-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A21CC843A / 2 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH R93692 / 2 UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Abdominal distension, Adenovirus test, Autopsy, Blood culture negative, Blood fibrinogen increased, Body temperature decreased, Bordetella test negative, C-reactive protein increased, CSF culture negative, CSF glucose, CSF protein, CSF red blood cell count positive, CSF white blood cell count increased, Cardio-respiratory arrest, Chlamydia test negative, Coagulation test normal, Computerised tomogram abnormal, Computerised tomogram head normal, Culture stool negative, Cyanosis, Decreased appetite, Diarrhoea, Enterovirus test negative, Gastrooesophageal reflux disease, Haematochezia, Haemoglobin decreased, Human metapneumovirus test, Human rhinovirus test, Hypotonia, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Lymphocyte percentage increased, Mycoplasma test negative, Neutrophil percentage decreased, Pallor, Platelet count increased, Procalcitonin increased, Respiratory syncytial virus test negative, Resuscitation, Skeletal survey normal, Sudden infant death syndrome, Viral test negative, White blood cell count increased, Whole body scan
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Agranulocytosis (broad), Haematopoietic erythropenia (broad), Haematopoietic leukopenia (broad), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Pseudomembranous colitis (broad), Gastrointestinal haemorrhage (narrow), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific dysfunction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Neonatal disorders (narrow), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Noninfectious diarrhoea (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Sepsis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2017-03-22
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Enteral nutrition (complete enteral nutrition possible from Day13); Mechanical ventilation (until Day 6); Neonatal jaundice; Neonatal respiratory distress (transient neonatal respiratory distress requiring ventilation until Day 6); Phototherapy (from Day 3 to Day 7); Prematurity (birth at 31 weeks)
Allergies:
Diagnostic Lab Data: Test Date: 20170322; Test Name: Adenovirus serology NOS; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Blood culture; Result Unstructured Data: Test Result: 2 distinct cultures negative; Test Date: 201703; Test Name: Fibrinogen; Result Unstructured Data: Test Result: 5.1, Test Result Unit: g/l; Test Date: 201703; Test Name: Blood pressure; Result Unstructured Data: Test Result: 69/54, Test Result Unit: mmHg; Test Date: 20170322; Test Name: Body height; Result Unstructured Data: Test Result: 54; Test Date: 201703; Test Name: Body temperature; Result Unstructured Data: Test Result: 37.1, Test Result Unit: Centigrade; Test Date: 20170322; Test Name: Body temperature; Result Unstructured Data: Test Result: 33.7, Test Result Unit: Centigrade; Test Date: 20170322; Test Name: Body temperature; Result Unstructured Data: Test Result: 32, Test Result Unit: Centigrade; Test Date: 20170322; Test Name: Bordetella test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Bordetella test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Chlamydia test; Result Unstructured Data: Test Result: negative; Test Date: 201703; Test Name: Coagulation test; Result Unstructured Data: Test Result: normal; Test Date: 20170322; Test Name: Whole body CAT; Result Unstructured Data: Test Result: no pneumoperitoneum, no intraperitoneal effusion; Test Date: 20170322; Test Name: Brain CT; Result Unstructured Data: Test Result: neither intra nor peri-cerebral hemorrhagic lesion; Test Date: 201703; Test Name: C-reactive protein; Result Unstructured Data: Test Result: 22, Test Result Unit: mg/l; Test Date: 20170322; Test Name: C-reactive protein; Result Unstructured Data: Test Result: 19, Test Result Unit: mg/l; Test Name: CSF culture; Result Unstructured Data: Test Result: negative, no germ; Test Date: 20170322; Test Name: CSF glucose; Result Unstructured Data: Test Result: 1.9, Test Result Unit: mmol/l; Test Date: 20170322; Test Name: CSF protein; Result Unstructured Data: Test Result: 0.95, Test Result Unit: g/l; Test Date: 20170322; Test Name: CSF red blood cell count; Result Unstructured Data: Test Result: 3; Test Date: 20170322; Test Name: CSF white blood cell count; Result Unstructured Data: Test Result: 26; Test Date: 20170322; Test Name: Culture; Result Unstructured Data: Test Result: polymorph flora; Test Date: 20170322; Test Name: Stool culture; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Enterovirus test; Result Unstructured Data: Test Result: negative; Test Date: 201703; Test Name: Hemoglobin; Result Unstructured Data: Test Result: 10, Test Result Unit: g/dl; Test Date: 20170322; Test Name: Hemoglobin; Result Unstructured Data: Test Result: 7.9, Test Result Unit: g/dl; Test Date: 20161219; Test Name: Head circumference; Result Unstructured Data: Test Result: 28; Test Date: 201703; Test Name: Heart rate; Result Unstructured Data: Test Result: 168; Test Date: 20170322; Test Name: Human rhinovirus test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Influenza A virus test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Influenza B virus test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Influenza serology; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Lumbar puncture; Result Unstructured Data: Test Result: clear and colorless cerebrospinal fluid; Test Date: 20170322; Test Name: Lymphocyte count; Test Result: 83 %; Test Date: 20170322; Test Name: Mycoplasma test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Neutrophil count; Test Result: 14 %; Test Date: 201703; Test Name: Oxygen saturation; Test Result: 100 %; Test Date: 201703; Test Name: Physical examination; Result Unstructured Data: Test Result: good general condition; Test Date: 20170322; Test Name: Physical examination; Result Unstructured Data: Test Result: normal; Test Date: 20170322; Test Name: Physical examination; Result Unstructured Data: Test Result: no rash, soft abdomen,no sign suggestive of trauma; Test Date: 20170322; Test Name: Platelet count; Result Unstructured Data: Test Result: 496000; Test Date: 201703; Test Name: Platelet count; Result Unstructured Data: Test Result: 435, Test Result Unit: x10 9/l; Test Date: 20170322; Test Name: Procalcitonin; Result Unstructured Data: Test Result: 0.00029, Test Result Unit: ug/ml; Test Date: 20170322; Test Name: Respiratory syncytial virus serology; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: X-ray of whole skeleton; Result Unstructured Data: Test Result: no traumatic bone injury; Test Date: 20170322; Test Name: Viral test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Viral test; Result Unstructured Data: Test Result: negative; Test Date: 20170322; Test Name: Viral test; Result Unstructured Data: Test Result: negative; Test Date: 201703; Test Name: Weight; Test Result: 3870 g; Test Date: 20170322; Test Name: Weight; Test Result: 3798 g; Test Date: 20170322; Test Name: Weight; Test Date: 20170322; Test Name: Leukocyte count NOS; Result Unstructured Data: Test Result: 35500
CDC Split Type: FRPFIZERINC2017157577

Write-up: This is a spontaneous report received from the Agency, regulatory authority report number FR-AFSSAPS-PB20170386. A 03-month-old female patient of an unspecified race received the second dose of PREVENAR 13 (lot number R93692) at 0,5ml single dose and the second dose of INFANRIX HEXA (ACELLULAR), manufacturer GlaxoSmithKline, (lot number A21CC843A) at 1DF single dose both by unspecified route, on 20Mar2017 for immunization. The first dose of both vaccines were administered on 03Feb2017. Relevant medical history included prematurity with birth at 31 weeks post-last menstrual period by cesarean-section performed emergently for severe pre-eclampsia. At birth weight was 1290 g, height 39 cm and head circumference 28 cm. She then had transient neonatal respiratory distress requiring ventilation until day 6, neonatal jaundice requiring phototherapy from day 3 to day 7, and complete enteral nutrition possible from day 13. The outcome of prematurity was satisfactory with good general condition. No concomitant treatment was reported. On 22Mar2017, the patient was the subject of sudden infant death. On 20Mar2017, for 3-month visit at child the examination was normal. On that day, the mother reported one previous episode of blood traces in stools but nothing was observed during the examination. The mother was advised to consult the emergency room in case of recurrence. Second injection of vaccination with pneumococcal 13-valent conjugate vaccine and Diphtheria, Tetanus, acellular Pertussis, Hepatitis b, inactivated Poliomyelitis and conjugated Haemophilus influenzae type b vaccines was performed. On 21Mar2017, the mother noticed several diarrhea episodes for 2-3 days, with some reflux more important than usual. In the evening, the mother worried about a trickle of red blood in each stool. The mother visited the emergency room at 11:23 pm: the patient was in good general condition, with a weight of 3870 g, temperature at 37.1?C, heart rate at 168 beats per minute, blood pressure at 69/54mmHg, and saturation of 100%. No constipation, no abdominal discomfort, no vomiting, no malaise were found. Laboratory tests revealed hemoglobin 10 g/dl, platelet count 435x10^9/l, normal coagulation, fibrinogen 5.1 g/l, C-reactive protein 22 mg/l. It was advised to come again the following day to perform stool culture. The patient was discharged from the emergency room at 4:27 am. The mother reported to have given a bottle of milk but the patient drunk a little. Then the mother placed the baby on her back in the bed. She gave another bottle of milk at 06:00 am but the patient drunk just a little (not a full bottle). The patient was put in her bed. At 09:25 am, the patient was found lifeless on her bed, very pale, with mild cyanosed lips, and open mouth, in cardio-respiratory arrest. The body temperature seemed normal. The patient was hypotonic. The first aid techniques were performed. The emergency medical service was called: complete resuscitation was performed but cardiac activity did not recover. The temperature was 33.7?C. On admission to the hospital, the baby was "nice" with no sign of dehydration, weight of 3798 g, height of 54 cm, head circumference of 35 cm, temperature of 32?C. No rash, soft abdomen, no sign suggestive of trauma. Additional tests: complete blood count revealed leukocyte count at 35 500 with 83% of lymphocytes and 14% of neutrophils, hemoglobin at 7.9 g/dl, platelet count at 496 000; C-reactive protein at 19 mg/l, procalcitonin at 0.29 ug/l. 2 distinct blood cultures returned negative, lumbar puncture revealed clear and colorless cerebrospinal fluid with protein 0.95 g/l, glucose 1.9 mmol/l, 3 red blood cells, 26 leukocytes and, no germ. Cerebrospinal fluid culture and Enterovirus test returned negative. The tracheal flora was polymorph; Mycoplasma pneumoniae, Chlamydia pneumoniae, Bordetella pertussis and para-pertussis tests were negative. Viral serology returned negative for Influenza A and B, Para-influenza, Respiratory syncytial virus, Adenovirus, Bocavirus, Metapneumovirus, Coronavirus, and Rhinovirus. Stool culture was negative. Squeleton X-ray revealed no traumatic bone injury. Brain computed tomography scan revealed no intra or pericerebral hemorrhagic lesion, no midline shift. Full body computed tomography scan revealed gastric distension, no pneumoperitoneum, and no intraperitoneal effusion. Autopsy results were pending. Based on the Official Method of Causality Assessment, the causal relationship between pneumococcal 13-valent conjugate vaccine and Diphtheria, Tetanus, acellular Pertussis, Hepatitis b, inactivated Poliomyelitis and conjugated Haemophilus influenzae type b vaccines and the adverse event sudden infant death was assessed by the Agency as "doubtful". No FU attempts possible. No further information expected. Reported Cause(s) of Death: Sudden infant death syndrome.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&GROUP2=VMAN&GROUP3=VDO&GROUP4=DEAY&EVENTS=ON&SYMPTOMS[]=Arterial+thrombosis+%2810003178%29&SYMPTOMS[]=Arterial+thrombosis+limb+%2810003180%29&SYMPTOMS[]=Axillary+vein+thrombosis+%2810003880%29&SYMPTOMS[]=Blood+fibrinogen+increased+%2810005521%29&SYMPTOMS[]=Complement+factor+C1+increased+%2810051554%29&SYMPTOMS[]=Complement+factor+C3+increased+%2810010126%29&SYMPTOMS[]=Complement+factor+C4+increased+%2810050982%29&SYMPTOMS[]=Complement+factor+increased+%2810061049%29&SYMPTOMS[]=Deep+vein+thrombosis+%2810051055%29&SYMPTOMS[]=Platelet+adhesiveness+increased+%2810035515%29&SYMPTOMS[]=Platelet+dysfunction+%2810073391%29&SYMPTOMS[]=Platelet+function+test+abnormal+%2810061539%29&SYMPTOMS[]=Pulmonary+embolism+%2810037377%29&SYMPTOMS[]=Secondary+thrombocytosis+%2810083158%29&SYMPTOMS[]=Thrombectomy+%2810043530%29&SYMPTOMS[]=Thrombin-antithrombin+III+complex+increased+%2810053968%29&SYMPTOMS[]=Thrombin+time+abnormal+%2810051319%29&SYMPTOMS[]=Thrombocytopenia+%2810043554%29&SYMPTOMS[]=Thrombocytopenic+purpura+%2810043561%29&SYMPTOMS[]=Thrombolysis+%2810043568%29&SYMPTOMS[]=Thrombophlebitis+%2810043570%29&SYMPTOMS[]=Thrombosis+%2810043607%29&SYMPTOMS[]=Thrombotic+microangiopathy+%2810043645%29&SYMPTOMS[]=Thrombotic+stroke+%2810043647%29&SYMPTOMS[]=Thrombotic+thrombocytopenic+purpura+%2810043648%29&SYMPTOMS[]=Vena+cava+embolism+%2810047193%29&SYMPTOMS[]=Vena+cava+thrombosis+%2810047195%29&SYMPTOMS[]=Venous+occlusion+%2810058990%29&VAX[]=FLU(H1N1)&VAX[]=FLU3&VAX[]=FLU4&VAX[]=FLUA3&VAX[]=FLUA4&VAX[]=FLUC3&VAX[]=FLUC4&VAX[]=FLUN(H1N1)&VAX[]=FLUN3&VAX[]=FLUN4&VAX[]=FLUR3&VAX[]=FLUR4&VAX[]=FLUX&VAX[]=FLUX(H1N1)&VAX[]=H5N1&VAX[]=PNC&VAX[]=PNC10&VAX[]=PNC13&VAX[]=PPV&VAX[]=VARZOS&VAXTYPES[]=Influenza&VAXTYPES[]=Pneumonia&VAXTYPES[]=Shingles&DIED=Yes&VAX_YEAR_LOW=2017&VAX_YEAR_HIGH=2018


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166